Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2025-12-24 @ 6:50 PM
NCT ID:
NCT04087057
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with primary invasive breast cancer
* For patients receiving adjuvant chemotherapy: First dose of chemotherapy administered \>= 60 days after definitive breast cancer surgery. For patient treated with neoadjuvant chemotherapy: First dose of chemotherapy administered \>= 60 days after pathological diagnosis
* Diagnosis of breast cancer within three years of study enrollment
* Can speak, read, and understand English and/or Spanish
* Patient of Lyndon B. Johnson General Hospital-Harris Health System (LBJ-HHS) or MD Anderson Cancer Center
Exclusion Criteria:
* Women hospitalized for a critical condition or who are considered medically unstable by their medical team
* Patients that started chemotherapy \>= 3 years after definitive breast cancer surgery
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04087057
Study Brief:
Protocol Section:
NCT04087057